Evaluation of the Coexistence of Acute Cerebrovascular Disease and Covid-19

Abstract

Objective: The aim of this study is to investigate the differences between acute cerebrovascular disease (CVD) with COVID-19 and acute cerebrovascular disease (CVD) without COVID-19.
Methods: This was a single-center, retrospective study. Using the database of the University of Health Sciences Kanuni Sultan Süleyman Training and Research Hospital, In this study was analyzed 84 cases of CVD with COVID-19 and 56 cases of CVD without COVID-19.  Statistical comparisons were performed using the Mann–Whitney U test and Pearson Chi-Square test.
Results: There were no significant differences between the two groups in terms of age, gender, or comorbidities (p > 0.05). The rates of large vessel occlusion, ischemic stroke, single lesion, anterior circulation lesion, and left hemisphere lesions were high in both groups. But there were no significant differences between the two groups. However, hemorrhagic stroke, multiple territory involvement, and mortality rates were significantly higher in the CVD with COVID-19 group compared to the CVD-only group (p < 0.05).

Urea, BUN, AST, CK, CRP, direct bilirubin, ferritin, neutrophil count and percentage, immunoglobulin percentage, INR, PTsec, immunoglobulin, and troponin T levels were significantly higher (p < 0.05) in the CVD with COVID-19 group. Meanwhile, GFR, Cl, Ca, albumin, RBC, lymphocyte count and percentage, monocyte percentage, basophil count and percentage, and PT% were significantly lower (p < 0.05) in the CVD with COVID-19 group.
Conclusions: The findings indicate that COVID-19 may contribute to more severe neurovascular complications and is associated with increased mortality rates.

Keywords

• COVID-19
• Cerebrovascular disease
• Stroke
• Neurovascular complication

Ethical Statement

To conduct the study, permission numbered 2021.01.211 was obtained from the Ministry of Health and our hospital's ethics committee.

References

1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683-90. doi:10.1001/jamaneurol.2020.1127.
2. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:2950-73. doi:10.1016/j.jacc.2020.04.031.
3. Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci. 2022;43(1):67-79. doi:10.1007/s10072-021-05679-0.
4. Morassi M, Bagatto D, Cobelli M, D'Agostini S, Gigli GL, Bnà C, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol 2020;267:2185-92. doi:10.1007/s00415-020-09885-2
5. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmes SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91:889-91. doi:10.1136/jnnp-2020-323586.
6. Hern´andez-Fern´andez F, Valencia HS, Barbella-Aponte RA, Collado-Jiménez R, Ayo-Martín Ó, Barrena C, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143:3089-103. doi:10.1093/brain/awaa239.
7. John S, Kesav P, Mifsud VA, Piechowski-Jozwiak B, Dibu J, Bayrlee A, et al. Characteristics of large-vessel occlusion associated with COVID-19 and ischemic stroke. AJNR Am J Neuroradiol. 2020;41(12):2263-68. doi:10.3174/ajnr.A6799.
8. Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke. 2020;15:385-9. doi:10.1177/1747493020921664.

9. Miller EC, Elkind MS. Infection and stroke: an update on recent progress. Curr Neurol Neurosci Rep. 2016;16(1):2. doi:10.1007/s11910-015-0602-9.
10. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020;382(20):e60. doi:10.1056/NEJMc2009787.
11. Ashrafi F, Zali A, Ommi D, Salari M, Fatemi A, Arab-Ahmadi M, et al. COVID-19-related strokes in adults below 55 years of age: a case series. Neurol Sci. 2020;41(8):1985-9. doi:10.1007/s10072-020-04521-3.
12. Khan M, Ibrahim RHM, Siddiqi SA, Kerolos Y, Al-Kaylani MM, AlRukn SA, et al. COVID-19 and acute ischemic stroke a case series from Dubai, UAE. Int J Stroke. 2020;15(6):699-700. doi:10.1177/1747493020938285
13. Wang A, Mandigo GK, Yim PD, Meyers PM, Lavine SD. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics. J NeuroInterv Surg. 2020;12(7):648-53. doi:10.1136/neurintsurg-2020-016220.
14. Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literatüre. J Thromb Thrombolysis. 2020;50(3):587-95. doi:10.1007/s11239-020-02228-y.
15. Güneysu F, Durmuş E, Yürümez Y. Evaluation of the blood parameters success in predicting the COVID-19 patients applying to the emergency room in the COVID-19 pandemic. Sakarya Med J. 2021;11(3):479-88. doi:10.31832/smj.930242.
16. Uchiyama T, Matsumoto M, Kobayashi N. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy. Thromb Res. 1990;59(6):955-65. doi:10.1016/0049-3848(90)90119-w.
17. Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. COVID-19 is an independent risk factor for acute ischemic stroke. Am J Neuroradiol. 2020. doi:10.3174/ajnr.A6650.
18. Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia. Lombardy, Italy. Neurology. 2020;95(7):e910-20. doi:10.1212/WNL.0000000000009848.
19. Escalard S, Maïer B, Redjem H, Delvoye F, Hébert S, Smajda S, et al. Treatment of acute ischemic stroke due to large vessel occlusion with COVID-19: experience from Paris. Stroke. 2020;51(8):2540-3. doi:10.1161/STROKEAHA.120.030574.
20. Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, et al. Risk of ischemic stroke in patients with Coronavirus Disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020;77(11):1366-72. doi:10.1001/jamaneurol.2020.2730.
21. Sierra-Hidalgo F, Munoz-Rivas N, Torres Rubio P, Chao K, Villanova Martínez M, Arranz García P, et al. Large artery ischemic stroke in severe COVID-19. J Neurol. 2020;267(12):3441-3. doi:10.1007/s00415-020-09967-1.
22. Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera JA, Troxel AB, et al. Covid-19 and ischemic stroke. Eur J Neurol. 2021;28(11):3826-36. doi:10.1111/ene.15008.
23. Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS, et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95(14):e2016-e2027. doi:10.1212/WNL.0000000000010116.
24. Jain R, Young M, Dogra S, Kennedy H, Nguyen V, Jones S, et al. COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci. 2020;414:116923. doi:10.1016/j.jns.2020.116923.
25. Kremer S, Lersy F, de Seze J, Ferré JC, Maamar A, Carsin-Nicol B, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297(2):E242-51. doi:10.1148/radiol.2020202222.
26. Vogrig A, Bagatto D, Gigli GL, Cobelli M, D'Agostini S, Bnà C, et al. Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research. J Neurol. 2021;268(3):758-61. doi:10.1007/s00415-020-10103-2.
27. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5.
28. Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-20. doi:10.1515/cclm-2020-0188.
29. Barrios-Lopez JM, Rego-Garcia I, Muroz Martinez C, Romero-Fábrega JC, Rivero Rodríguez M, Ruiz Giménez JA, et al. Ischaemic stroke and SARSCoV- 2 infection: a causal or incidental association? Neurologia. 2020;35(5):295-302. doi:10.1016/j.nrl.2020.05.002.
30. Yang F, Zhao H, Liu H, Wu X, Li Y. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV. Brain Res Bull. 2021;177:155-63. doi:10.1016/j.brainresbull.2021.09.015.